glp 1 pancreas GLP-1 receptor biology: structure, signaling, and distribution GLP-1: Actions on Beta-cell Mass

Semaglutide: the pure GLP-1 approach Semaglutide is a pure GLP-1 receptor agonist

PPPY, per patient per year

This coordinated engagement across the pancreas, brain, gut, liver, and adipose tissue underlies the mechanistic rationale for dual GLP-1/GIP receptor agonists, and explains why they have been described as super GLP-1RAs, reflecting genuine potentiation of GLP-1 action by GIP receptor agonist co-activation

GLP-1s suppress appetite so effectively that many people struggle to eat enough volume to hit their protein target

Ethics statement The Western Institutional Review Board approved a waiver of informed consent for TriNetX, as the platform solely compiles and presents de-identified data in aggregate form [32]

Acknowledgements I would like to thank my former PhD students and post-docs Anne Raben, Anne Flint, Camilla Verdich, Birgitte Sloth, Helle Harder, Anita Belza and Thomas Meinert Larsen for their invaluable contributions to the research described in this article